Hello Peptide Launches Consumer Education Platform as Post-Category-2 Peptide Curiosity Surges
Hello Peptide announced an expansion of its digital platform HelloPeptide.net on April 30, positioning it as a research-aligned consumer education resource for adults navigating GLP-1 and peptide-therapy decisions. The launch is timed to a documented surge in consumer search and telehealth inquiries that followed the FDA's April 22 Category 2 removal of 12 peptides and the upcoming July 23–24 PCAC meeting. The platform sits alongside FormBlends' 2026 State of Peptides report and a wave of legacy-media safety primers as the post-restriction information ecosystem takes shape.